01 1Agno Pharma
01 1SULINDAC
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-09-26
Pay. Date : 2025-09-08
DMF Number : 42166
Submission : 2025-07-11
Status : Active
Type : II
20
Agno Pharma, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SULINDAC, with a corresponding US DMF Number 42166.
Remarkably, this DMF maintains an Active status since its submission on July 11, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 26, 2025, and payment made on September 08, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
